These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 33991233)

  • 1. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
    Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
    Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy.
    Luan M; Wei L; Sun Y; Chen J; Jiang Y; Wu W; Li F; Sun W; Zhu L; Wang Z; Deng J
    Parkinsonism Relat Disord; 2024 Oct; 127():107088. PubMed ID: 39111257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
    Jiang C; Hopfner F; Katsikoudi A; Hein R; Catli C; Evetts S; Huang Y; Wang H; Ryder JW; Kuhlenbaeumer G; Deuschl G; Padovani A; Berg D; Borroni B; Hu MT; Davis JJ; Tofaris GK
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):720-729. PubMed ID: 32273329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
    Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
    Front Immunol; 2019; 10():2253. PubMed ID: 31616427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
    Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease.
    Folke J; Rydbirk R; Løkkegaard A; Hejl AM; Winge K; Starhof C; Salvesen L; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
    Parkinsonism Relat Disord; 2021 Jun; 87():98-104. PubMed ID: 34020303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].
    Yan XM; Li PJ; Li W; Wang XM; Yu S
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2933-2939. PubMed ID: 37752052
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser
    Dutta S; Hornung S; Taha HB; Biggs K; Siddique I; Chamoun LM; Shahpasand-Kroner H; Lantz C; Herrera-Vaquero M; Stefanova N; Loo JA; Bitan G
    ACS Chem Neurosci; 2023 Apr; 14(7):1238-1248. PubMed ID: 36920792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
    Taha HB; Ati SS
    CNS Neurosci Ther; 2023 Dec; 29(12):3741-3755. PubMed ID: 37416941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
    Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
    Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases.
    Ohmichi T; Mitsuhashi M; Tatebe H; Kasai T; Ali El-Agnaf OM; Tokuda T
    Parkinsonism Relat Disord; 2019 Apr; 61():82-87. PubMed ID: 30502924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.
    Zheng Y; Yu Z; Cai H; Kou W; Yang C; Li S; Zhang N; Feng T
    Mov Disord; 2024 Aug; 39(8):1300-1309. PubMed ID: 38715177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
    Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
    J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).
    Katzdobler S; Nübling G; Klietz M; Fietzek UM; Palleis C; Bernhardt AM; Wegner F; Huber M; Rogozinski S; Schneider LS; Spruth EJ; Beyle A; Vogt IR; Brandt M; Hansen N; Glanz W; Brockmann K; Spottke A; Hoffmann DC; Peters O; Priller J; Wiltfang J; Düzel E; Schneider A; Falkenburger B; Klockgether T; Gasser T; Nuscher B; Haass C; Höglinger G; Levin J
    J Neurol; 2024 Oct; 271(10):6991-6999. PubMed ID: 39254698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X; Yu S; Li F; Feng T
    Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.